Conference Agenda
Day 1, Friday, March 05, 2021
2:00 p.m. - 2:05 p.m.
Welcome
Virginia E. Anello, Douglas & London, P.C., New York
Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York
2:05 p.m. - 2:20 p.m.
Elmiron: Important Updates on the MDL and Defendants
Virginia E. Anello, Douglas & London, P.C., New York
2:20 p.m. - 2:35 p.m.
The Science of the Drug and the Injury
Danielle Ward Mason, Sanders Phillips Grossman, LLC, Garden City, NY
2:35 p.m. - 2:50 p.m.
The Studies Linking Elmiron to the Signature Injury
Aimee H. Wagstaff, Andrus Wagstaff, Denver
2:50 p.m. - 3:05 p.m.
Liability and Marketing Issues
D. Nicole “Nikki” Guntner, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL
3:05 p.m. - 3:20 p.m.
Case Selection Criteria Based on Science, Studies, Intake, and Case Evaluation
Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York
3:20 p.m. - 3:30 p.m.
Roundtable Discussion of Any Issues that Are Unique to the Elmiron Litigation
Virginia E. Anello, Douglas & London, P.C., New York
Rachel L. Shkolnik, Napoli Shkolnik PLLC, New York
Aimee H. Wagstaff, Andrus Wagstaff, Denver
Danielle Ward Mason, Sanders Phillips Grossman, LLC, Garden City, NY
D. Nicole “Nikki” Guntner, Aylstock, Witkin, Kreis & Overholtz, PLLC, Pensacola, FL